SCR-1481B1

CAS No. 1174161-86-4

SCR-1481B1( c-Met inhibitor 2 )

Catalog No. M20163 CAS No. 1174161-86-4

SCR-1481B1 has activity against cancers dependent on Met activation and also has activity against cancers as a VEGFR inhibitor.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 41 In Stock
5MG 65 In Stock
10MG 110 In Stock
25MG 200 In Stock
50MG 332 In Stock
100MG 494 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    SCR-1481B1
  • Note
    Research use only, not for human use.
  • Brief Description
    SCR-1481B1 has activity against cancers dependent on Met activation and also has activity against cancers as a VEGFR inhibitor.
  • Description
    SCR-1481B1 has activity against cancers dependent on Met activation and also has activity against cancers as a VEGFR inhibitor.(In Vitro):More details please refer to Patent WO 2009094417 A1.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    c-Met inhibitor 2
  • Pathway
    Angiogenesis
  • Target
    VEGFR
  • Recptor
    VEGFR1
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1174161-86-4
  • Formula Weight
    742.07
  • Molecular Formula
    C31H35ClF2N5O10P?
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:31 mg/mL?(44.29 mM)
  • SMILES
    NC(CO)(CO)CO.NC(CO)(CO)CO.Nc1nccc(Oc2ccc(NC(=O)c3cn(COP(O)(O)=O)cc(-c4ccc(F)cc4)c3=O)cc2F)c1Cl
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Robert M. Borzilleri et al. 4-pyridinone compounds and their use for cancer. WO/2009094417/A1.
molnova catalog
related products
  • AAL-993

    AAL-993 is a potent VEGFR inhibitor with IC50s of 130 nM, 23 nM and 18 nM for VEGFR1, VEGFR2 and VEGFR3, respectively.

  • Vorolanib

    Vorolanib is an orally active VEGFR/PDGFR dual inhibitor.

  • Lenvatinib

    Lenvatinib (E7080) is a multitargeted kinase inhibitor with IC50s of 4/5.2/22/46 nM for VEGFR2/VEGFR3/VEGFR1/FGFR1 in cell free assays.